Endovia Health Sciences, Inc. short interest in 2023
In 2023, Endovia Health Sciences, Inc.'s disclosed short interest ran from 1.66% of shares outstanding on 13 Jan 2023 to 0.81% on 29 Dec 2023, a change of -0.85 percentage points. The year's high was 1.66% on 13 Jan 2023 and its low 0.25% on 15 May 2023, averaging 0.73% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.75 days on 31 Jul 2023. Full history: Endovia Health Sciences, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 1.66% (13 Jan 2023)
- End of year
- 0.81% (29 Dec 2023)
- Change
- -0.85 pp
- High
- 1.66% (13 Jan 2023)
- Low
- 0.25% (15 May 2023)
- Average
- 0.73%
- Highest days to cover
- 3.75 (31 Jul 2023)
- SEC filings marked
- 5
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 1.66% | 2.35 | |
| 31 Jan 2023 | 1.47% | 3.57 | |
| 15 Feb 2023 | 0.71% | 1.63 | |
| 28 Feb 2023 | 0.38% | 1.00 | |
| 15 Mar 2023 | 0.42% | 1.00 | |
| 31 Mar 2023 | 0.37% | 1.00 | 10-K filed |
| 14 Apr 2023 | 0.38% | 1.00 | |
| 28 Apr 2023 | 0.33% | 1.00 | |
| 15 May 2023 | 0.25% | 1.00 | |
| 31 May 2023 | 0.26% | 1.00 | |
| 15 Jun 2023 | 0.61% | 1.28 | 10-Q filed |
| 30 Jun 2023 | 0.56% | 1.00 | |
| 14 Jul 2023 | 0.79% | 2.78 | |
| 31 Jul 2023 | 0.66% | 3.75 | |
| 15 Aug 2023 | 0.97% | 1.00 | 10-Q filed |
| 31 Aug 2023 | 0.76% | 1.00 | results (8-K) |
| 15 Sep 2023 | 0.66% | 1.93 | |
| 29 Sep 2023 | 0.73% | 2.49 | |
| 13 Oct 2023 | 0.92% | 1.92 | |
| 31 Oct 2023 | 1.19% | 3.38 | |
| 15 Nov 2023 | 0.94% | 1.96 | 10-Q filed |
| 30 Nov 2023 | 0.77% | 2.55 | |
| 15 Dec 2023 | 0.84% | 3.69 | |
| 29 Dec 2023 | 0.81% | 2.52 |
See also: Endovia Health Sciences, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.